MOR News and Press, MorphoSys AG From 03/17/24

2024-03-17 00:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-14 10:00:25 ET MorphoSys AG (MOR) Q3 2023 Earnings Conference Call March 14, 2024 08:00 a.m. ET Company Participants Jean-Paul Kress - Chief Executive Officer Tim Demuth - Chief Research and Development Officer Lucinda Crabtree - Chief Financial Officer ...

2024-03-13 16:25:17 ET More on MorphoSys Novartis And MorphoSys Are A Perfect Match MorphoSys: Positive Pelabresib Data Finally Unlocking Upside MorphoSys ADRs gain after definitive merger agreement with Novartis disclosed Read the full article on Seeking A...

– Entered into Business Combination Agreement to be acquired by Novartis for € 68.00 per share in cash or € 2.7 billion equity value – Sold all tafasitamab rights worldwide to Incyte – Presented comprehensive Phase 3 MANIFEST-2 study results at...

SuRo Capital Corp. (SSSS) is expected to report for quarter end 2023-12-31 Enviva Inc. (EVA) is expected to report $-0.76 for Q4 2023 Jushi Holdings Inc. - Class B (Sub Voting) (JUSHF) is expected to report $-0.04 for Q4 2023 U Power Limited (UCAR) is expected to report for quarter en...

2024-03-12 17:35:31 ET Major earnings expected after the bell on Wednesday include: UiPath ( PATH ) SentinelOne ( S ) Lennar Corporation ( LEN ) GrowGeneration Corp. ( GRWG ) Limbach Holdings ( LMB ) Read the full article on Seeking Alpha ...

2024-03-11 15:54:09 ET More on Cytokinetics Cytokinetics, Incorporated (CYTK) Q4 2023 Earnings Call Transcript Cytokinetics Steps Up As Prime Target After Aficamten's HCM Triumph (Rating Upgrade) Cytokinetics: Clear Win For Aficamten In SEQUOIA-HCM Phase 3 Trial (Upg...

2024-03-10 13:08:00 ET More on ALX Oncology, Bicycle Therapeutics, etc. Immunocore Holdings plc (IMCR) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. (KURA) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. 2023 Q4 - Results - Earnings Call Presentation ...

Conference Call Alert PLANEGG and MUNICH, GERMANY / ACCESSWIRE / March 7, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) will publish its results for the financial year 2023 on March 13, 2024, at 09:00 pm CET (08:00 pm GMT; 04:00 pm EDT). MorphoSys' Management team will host a conference call an...

2024-02-24 21:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...